A Single-Center, Randomized, Open-Label, Two-Formulation, Two-Sequence, Two-Period Crossover Study to Evaluate the Bioequivalence of Two Eltrombopag Olamine Tablets (25 mg) in Healthy Chinese Subjects in the Fed State

Clinical Drug Investigation 2026

View at publisher

Authors: Keyi Wu, Qin Ren, Yanli Wang, Yannan Zhou, Zhengzhi Liu, Yang Cheng, Qiaohuan Deng, Yingzi Cui, Haimiao Yang

DOI: 10.1007/s40261-026-01528-0

Cited by: 0

Fields of Study & Subjects

Platelet Disorders and Treatments Biosimilars and Bioanalytical Methods Statistical Methods in Clinical Trials